Summary
Alexo Therapeutics
Founded in 2015
Description
ALX Oncology is a clinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Strengths
- Since Alexo Therapeutics was founded, the company has grown faster than the industry average
Weaknesses
- Alexo Therapeutics has a very small market share in their industry
- Revenue generated per employee is less than the industry average
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
- Variance of revenue growth is more than the industry average
Annual Revenue
Alexo Therapeutics's annual revenue
$9088000
Based on Kona Equity data
-
Revenue per employee
$206545
-
Variance of revenue growth
0.43
-
Annual revenue growth since founding
$1009777
-
Revenue growth rate from first known quarter to current
26.2%
Employee Count
44 employees
-
Employee growth rate from first known quarter to current
-5.3%
Executives
Nathan Caffo
Chief Business Officer
n**@alxoncology.comMichael Chang
Operations Vice President, Research & Development
m**@alxoncology.comJeanne Jew
Chief Business Officer
j**@alxoncology.comBilqees Akhtar
Senior Director, Regulatory Affairs
b**@alxoncology.comSelina Lau
Manager, Accounting
s**@alxoncology.comRichard Morishige
Director, Clinical Operations
r**@alxoncology.comHank Stern
Vice President, Chemistry, Manufacturing & Controls
h**@alxoncology.comSophia Randolph
Chief Medical Officer
s**@alxoncology.comSangeetha Bollini
Director, Program Management
s**@alxoncology.comShaira Tumaneng
Senior Accountant
s**@alxoncology.comSen Xu
Senior Director, Biologics Process Development
s**@alxoncology.comPeter Garcia
Chief Financial Officer
p**@alxoncology.comShanhong Guan
Senior Director, Head of Biometrics
s**@alxoncology.comSusan Vermeir
Vice President, Regulatory Affairs
s**@alxoncology.comJanica Wong
Associate Director, Discovery Biology
j**@alxoncology.comChristine Ju
Senior Manager, Biostatistics
c**@alxoncology.comShelly Pinto
Vice President, Finance & Chief Accounting Officer
s**@alxoncology.comSteffen Pietzke
Vice President, Finance & Chief Accounting Officer
s**@alxoncology.comMonica Meacham
Director, Regulatory Affairs
m**@alxoncology.comJaume Pons
CEO
j**@alxoncology.comG Score - 1
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Leap Therapeutics
leaptx.com- Founded in 2016
- Location: Cambridge, MA
- Annual Revenue: $1.1M
- Employees: 36
- Leap Therapeutics, Inc. (Nasdaq: LPTX) is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer patients. Their most advanced clinical candidate, DKN 01, is a humanized monoclonal antibody...
Aravive
aravive.com- Founded in 2008
- Location: Houston, TX
- Annual Revenue: $8.3M
- Employees: 23
- [av_one_half first min_height='' vertical_alignment='' space='' custom_margin='' margin='0px' row_boxshadow='' row_boxshadow_color='' row_boxshadow_width='10' link='' linktarget='' link_hover='' title_attr='' alt_attr='' padding='0px'
Cabaletta Bio, Inc.
cabalettabio.com- Founded in 2017
- Location: Philadelphia, PA
- Annual Revenue: $11.4M
- Employees: 56
- Cabaletta Bio discovers and develops targeted cell therapy product candidates to potentially cure patients with autoimmune diseases. Learn about our CAAR T cell products.
EpicentRx Inc
epicentrx.com- Founded in 2002
- Location: La Jolla, CA
- Annual Revenue: $6.8M
- Employees: 17
- Innovation-driven drug and device company with a focus on minimally toxic therapies for cancer and chronic diseases. #cancertherapy #biotech
Ocugen
ocugen.com- Founded in 2013
- Location: Malvern, PA
- Annual Revenue: $28.4M
- Employees: 84
- Ocugen Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patients lives throu...
Checkmate Pharmaceuticals Inc.
checkmatepharma.com- Founded in 2015
- Location: Cambridge, MA
- Annual Revenue: $10.1M
- Employees: 30
- Empowering the immune system to beat back cancer
Key Information
- Name: Alexo Therapeutics
- Industry: Biotechnology Company
- SIC: 283; 28
- NAICS: 541; 5417
See similar companies
-
By City Burlingame Small Biotechnology Company in Burlingame Mid-size Biotechnology Company in Burlingame
-
By State CA Small companies in CA Small Biotechnology Company in CA Mid-size Biotechnology Company in CA
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company
-
Firmographic data G Score of 1 Founded in 2015 SIC: 283 SIC: 28 NAICS: 541 NAICS: 5417 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Alexo Therapeutics's headquarters are located at 866 Malcolm Rd. Ste. 100 Burlingame, CA 94010.
Alexo Therapeutics's official website is alxoncology.com
Alexo Therapeutics's annual revenue is $9.1 M.
Alexo Therapeutics's SIC: 283; 28
Alexo Therapeutics's NAICS: 541; 5417.
Alexo Therapeutics has 44 employees
